King Faisal Prize 2028 – Medicine (RNA-Based Therapeutics) nominations
The King Faisal Prize 2028 in Medicine, on the topic of RNA-based therapeutics, invites nominations of researchers for published work, submitted by eligible institutions, with a prize of SR 750,000 (about US$200,000) plus a gold medallion. This guide covers research areas consistent with the topic, eligibility and readiness checks, what selection committees typically value and how to prepare a nomination before the 31 March 2027 deadline.
The published deadline has passed. Check the official page in case it has been extended, or browse the open listings.
Key dates
- Application deadline
- 31 March 2027
- Details last checked
- 10 November 2026
About the call
- Funder
- King Faisal Prize
- Country
- Saudi Arabia
- Scheme type
- Prize
- Funding
- SR 750,000 (about US$200,000) plus a gold medallion
- Eligibility
- Nominations of researchers for published work on RNA-based therapeutics, submitted by eligible institutions; self-nominations, posthumous nominations and past laureates are not accepted.
- Scope
- Pharmacology and drug development
Topics consistent with the call
- Messenger RNA therapeutics and vaccines for infectious and other diseases
- Small interfering RNA and RNA interference-based medicines
- Antisense oligonucleotides for genetic and acquired diseases
- Delivery systems for RNA therapeutics, including lipid nanoparticles
- RNA editing and RNA-targeting therapeutic strategies
- Chemical modification and design of therapeutic RNA molecules
Based on the published scope; the official page sets out the full themes and requirements.
Is your work a fit? Check before you apply
- Confirm that the nominee’s published work is on RNA-based therapeutics.
- Check that the nominating institution is eligible under the prize rules.
- Note that self-nominations, posthumous nominations and nominations of past laureates are not accepted.
- Assemble the nominee’s publications and supporting documents as required in the nomination guidelines.
- Submit a complete, institutionally approved nomination before 31 March 2027.
Why This Funding Call Matters
RNA-based therapeutics have moved from laboratory concept to approved medicines and vaccines, built on decades of work on RNA chemistry, delivery and biology. Recognising the researchers behind such advances draws attention to the field and to the long-term research that made it possible. For institutions, a well-prepared nomination is an opportunity to document the contribution of a leading scientist to an area of medicine with broad clinical potential.
Who Should Apply
Academic backgrounds
- RNA biology
- Molecular medicine
- Pharmacology and drug development
- Immunology and vaccinology
- Nanomedicine and drug delivery
Institutions and sectors
- Universities and medical schools
- Research institutes
- Academies and scientific societies eligible to nominate
What Reviewers Typically Value
- Published work that has made a foundational or transformative contribution to RNA-based therapeutics.
- Evidence that the nominee’s research has influenced the direction of the field.
- A clear account of how the work has benefited, or may benefit, patients.
- Recognition of the work by peers, demonstrated through its uptake and citation.
Ideas You Could Develop
Your Plan to the Deadline
A suggested schedule working back from 31 March 2027. Adjust it to the stage your work has reached.
By 3 Feb 2027
Read the call documents; confirm eligibility, budget limits, assessment criteria and institutional requirements.
By 17 Feb 2027
Agree the research question, aims, team and partners; contact your research office.
By 3 Mar 2027
Draft the case for support, methods, impact and budget.
By 17 Mar 2027
Obtain internal review, letters of support and institutional sign-off.
By 26 Mar 2027
Final checks against the funder’s guidance and formatting rules.
By 31 Mar 2027
Submit through the funder’s system before the deadline.
What you gain
- Funding for the research, team and resources it needs.
- Recognition from a competitive, peer-reviewed process.
- Reviewer feedback that strengthens future applications.
- A track record for larger grants and fellowships.
What happens after you apply
- Eligibility check: the funder confirms the application meets the call rules.
- Peer review: external reviewers assess the proposal against the published criteria.
- Panel: a committee ranks proposals; some schemes include an interview.
- Decision: outcomes are released on the funder’s timetable.
- Award: successful applicants agree terms and reporting requirements before starting.
What the Funder Are Looking For
The King Faisal Prize seeks nominations, made by eligible institutions, of researchers whose published work has advanced RNA-based therapeutics. Strong nominations typically set out the significance of the nominee’s contributions, their influence on the field and their relevance to medicine. Nomination rules, required documents and institutional eligibility should be confirmed on the official King Faisal Prize nominations page.
Expert help
How Pubrica Can Help
Pubrica’s subject specialists can help you prepare a competitive proposal, planned back from the deadline. You remain the author of your work.
FAQs
Questions Researchers Ask
The next published deadline is 31 March 2027. Dates can change, so confirm them on the official page before you plan your work.
Self-nominations are not accepted, and nominations must be submitted by eligible institutions. Check the King Faisal Prize nominations page to confirm which institutions may nominate and what documentation is required.
Nominations of researchers for published work on RNA-based therapeutics, submitted by eligible institutions; self-nominations, posthumous nominations and past laureates are not accepted. Confirm the full eligibility rules in the call documents.
Yes. Pubrica’s specialists can review, write, edit and format your proposal. You remain the author and the person responsible for the submission.
Sources
- King Faisal Prize. (2026). King Faisal Prize 2028 – Medicine (RNA-Based Therapeutics) nominations. Retrieved 10 November 2026, from https://kingfaisalprize.org/nominations/
How to cite this page
Pubrica Insights. (2026). King Faisal Prize 2028 – Medicine (RNA-Based Therapeutics) nominations. Pubrica. https://pubrica.com/insights/calls-and-conferences/king-faisal-prize-2028-medicine-rna-based-therapeutics-nominations/
Pubrica Insights. “King Faisal Prize 2028 – Medicine (RNA-Based Therapeutics) nominations.” Pubrica, 2026, https://pubrica.com/insights/calls-and-conferences/king-faisal-prize-2028-medicine-rna-based-therapeutics-nominations/.
Pubrica Insights (2026) King Faisal Prize 2028 – Medicine (RNA-Based Therapeutics) nominations. Pubrica. Available at: https://pubrica.com/insights/calls-and-conferences/king-faisal-prize-2028-medicine-rna-based-therapeutics-nominations/ (Accessed: 10 November 2026).
Pubrica Insights. King Faisal Prize 2028 – Medicine (RNA-Based Therapeutics) nominations [Internet]. Pubrica; 2026 [cited 2026 Nov 10]. Available from: https://pubrica.com/insights/calls-and-conferences/king-faisal-prize-2028-medicine-rna-based-therapeutics-nominations/
Funding call